Patents by Inventor Albert Gregory DiRienzo

Albert Gregory DiRienzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREDICTING PROSTATE CANCER AND USES THEREOF
    Publication number: 20230257826
    Abstract: The present invention relates to compositions and methods for diagnosing, prognosing, monitoring, and treating a patient with prostate cancer. In particular, the invention relates to the use of miRNA and snoRNA as expression signatures for identifying a clinically significant prostate cancer.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Applicant: miR Scientific, LLC
    Inventors: Martin Tenniswood, Albert Gregory DiRienzo, Wei-Lin Winnie Wang
  • Methods for predicting prostate cancer and uses thereof
    Patent number: 11661633
    Abstract: The present invention relates to compositions and methods for diagnosing, prognosing, monitoring, and treating a patient with prostate cancer. In particular, the invention relates to the use of miRNA and snoRNA as expression signatures for identifying a clinically significant prostate cancer.
    Type: Grant
    Filed: March 14, 2020
    Date of Patent: May 30, 2023
    Assignee: MIR SCIENTIFIC LLC
    Inventors: Martin Tenniswood, Albert Gregory DiRienzo, Wei-Lin Winnie Wang
  • METHODS FOR PREDICTING PROSTATE CANCER AND USES THEREOF
    Publication number: 20200291485
    Abstract: The present invention relates to compositions and methods for diagnosing, prognosing, monitoring, and treating a patient with prostate cancer. In particular, the invention relates to the use of miRNA and snoRNA as expression signatures for identifying a clinically significant prostate cancer.
    Type: Application
    Filed: March 14, 2020
    Publication date: September 17, 2020
    Applicant: miR Scientific, LLC
    Inventors: Martin Tenniswood, Albert Gregory DiRienzo, Wei-Lin Winnie Wang